Kingdon Capital Management’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-73,860
Closed -$135K 85
2022
Q1
$135K Sell
73,860
-251,140
-77% -$782K 0.01% 80
2021
Q4
$1.55M Sell
325,000
-75,000
-19% -$302K 0.18% 69
2021
Q3
$1.04M Hold
400,000
0.13% 58
2021
Q2
$1.19M Hold
400,000
0.14% 62
2021
Q1
$1.56M Buy
+400,000
New +$2.05M 0.16% 58
2019
Q2
Sell
-175,414
Closed -$6.63M 76
2019
Q1
$6.63M Buy
+175,414
New +$6.53M 0.89% 37

Other funds holding IFRX

Kingdon Capital Management's IFRX Position: Q2 2022 in Review

Kingdon Capital Management sold out of InflaRx (IFRX) in Q2 2022, closing a stake of 73,860 shares — an estimated $135K sold.

Kingdon Capital Management first reported a position in IFRX in Q1 2019 and held it in 6 quarters. The position peaked at $6.63M in Q1 2019. 27 funds tracked by Wall St. Rank hold IFRX as of Q2 2022.

  • Kingdon Capital Management reported no remaining InflaRx position as of Q2 2022 after selling out during the quarter.
  • Kingdon Capital Management sold 73,860 InflaRx shares in Q2 2022, an estimated $135K.
  • Kingdon Capital Management first reported a position in InflaRx in Q1 2019 and held it in 6 quarters.
  • Kingdon Capital Management's InflaRx position peaked at $6.63M in Q1 2019.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q2 2022.

Based on Kingdon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.